Morning News Leader: Johnson & Johnson (JNJ) Delivers Q1 Earnings Beat
Johnson & Johnson (JNJ) is up 2.3% Tuesday morning following the company’s better than expected first-quarter report. The company reported earnings of $2.10 per share, beating the consensus $2.03. Revenue for the quarter of $20.02 billion also topped estimates of $19.61 billion.
Johnson & Johnson (JNJ) is a diversified healthcare company.
The Progressive Corporation (PGR) and Roku, Inc. (ROKU) top the list of other companies with positive news today, while Bank of America Corporation (BAC) and J.B. Hunt Transport Services, Inc. (JBHT) top the list of companies with negative news.
Already a member?
Login to see your Morning News Leader Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.